To follow up on the possibility that p21 has oncogenic properties in neoplasms of mature B-lymphocytes, and to evaluate the clinical significance, if any, of up-regulation of CDKN1A, we interrogated publicly available gene expression profiles of human non-Hodgkin lymphomas and MM. The gene discussed is CDKN1A; the disease is neoplasm.